New Anti-Clotting Drug May Cut Brain Bleeding Risk: Study
Quick ReadPeople with abnormal heartbeat taking Xarelto were less likely to bleed out than warfarin patients
Photos
A new medication that helps prevent strokes in people with the abnormal heart rhythm disorder known as atrial fibrillation poses less risk of bleeding in the brain than a commonly used drug, research comparing rivaroxaban (Xarelto) and warfarin suggests.
Anti-clotting medications, also called blood-thinners or anticoagulants, include warfarin (Coumadin) and aspirin, among others. In patients...
